Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Tibsovo 250 mg film-coated tablets {equilateral_black_triangle}

Active Ingredient:
ivosidenib
Company:  
Servier Laboratories Limited See contact details
ATC code: 
L01XX62
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

DIRECT HEALTHCARE PROFESSIONAL COMMUNICATION - Tibsovo▼ 250 mg filmcoated tablets: Interim Supply of Irish packs to Mitigate Supply Disruption

{healthcare_pro_orange} For Healthcare Professionals
Servier Laboratories Limited is currently experiencing supply disruption with TIBSOVOâ–¼ (ivosidenib) in Great Britain. To ensure continuity in supply, Servier Laboratories Ltd has obtained approval from the MHRA to supply the Tibsovo 250 mg film-coated tablets product in Irish/Maltese Packaging, which is expected to be on the GB market to Q1 2025.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Servier Laboratories Limited
Company image
Address
Sefton House, Sefton Park, Bells Hill, Stoke Poges, Slough, SL2 4JS, UK
Telephone
+44 (0)1753 662744
Fax
+44 (0)1753 663456
Medical Information Direct Line
+44 (0)1753 666409
Medical Information e-mail
[email protected]